Original InvestigationStatin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction
Central Illustration
Key Words
Abbreviations and Acronyms
Cited by (0)
This study was supported by a research grant from Amgen, Inc. Dr. Rosenson has received research support from Amgen Inc., Eli Lilly, The Medicines Company, Regeneron, and Sanofi; serves on the advisory boards for Amgen Inc., Eli Lilly, Regeneron, and Sanofi. Drs. Manthripragada and Monda are employees of and hold stock in Amgen Inc. Dr. Dent is an employee of Esperion Therapeutics. At the time this study was conducted, Dr. Dent was an employee of Amgen Inc. Dr. Banach is member of the speakers bureau at Abbott/Mylan, Abbott Vascular, Actavis, Akcea, Amgen, Biofarm, KRKA, MSD, and Sanofi; is a consultant for Abbott Vascular, Amgen, Daichii-Sankyo, Esperion, MSD, Resverlogix, and Sanofi; and has received grants from Sanofi and Valeant. Dr. Bittner has participated in advisory panels for Amgen, Eli Lilly, and Pfizer; and has received research funding through her institution from Amgen, AstraZeneca, Dalcor, Bayer, and Sanofi. Dr. Kent has received salary support from Amgen. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.